Skip to main content
NCBI home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 1998 Nov;90(11 Suppl):S713–S719.

Is race an independent prognostic factor for survival from prostate cancer?

M Roach 3rd 1
PMCID: PMC2653096  PMID: 9828588

Full text

PDF
S713

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Austin J. P., Aziz H., Potters L., Thelmo W., Chen P., Choi K., Brandys M., Macchia R. J., Rotman M. Diminished survival of young blacks with adenocarcinoma of the prostate. Am J Clin Oncol. 1990 Dec;13(6):465–469. doi: 10.1097/00000421-199012000-00002. [DOI] [PubMed] [Google Scholar]
  2. Austin J. P., Convery K. Age-race interaction in prostatic adenocarcinoma treated with external beam irradiation. Am J Clin Oncol. 1993 Apr;16(2):140–145. doi: 10.1097/00000421-199304000-00012. [DOI] [PubMed] [Google Scholar]
  3. Aziz H., Rotman M., Thelmo W., Chen P., Choi K. N., Khil S. U., Laungani G. B., Brandys M., Ayr G., Macchia R. J. Radiation-treated carcinoma of prostate. Comparison of survival of black and white patients by Gleason's grading system. Am J Clin Oncol. 1988 Apr;11(2):166–171. doi: 10.1097/00000421-198804000-00015. [DOI] [PubMed] [Google Scholar]
  4. Braun M. M., Helzlsouer K. J., Hollis B. W., Comstock G. W. Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States) Cancer Causes Control. 1995 May;6(3):235–239. doi: 10.1007/BF00051795. [DOI] [PubMed] [Google Scholar]
  5. Carter B. S., Bova G. S., Beaty T. H., Steinberg G. D., Childs B., Isaacs W. B., Walsh P. C. Hereditary prostate cancer: epidemiologic and clinical features. J Urol. 1993 Sep;150(3):797–802. doi: 10.1016/s0022-5347(17)35617-3. [DOI] [PubMed] [Google Scholar]
  6. Cavalli-Sforza L. L. Genes, peoples and languages. Sci Am. 1991 Nov;265(5):104–110. doi: 10.1038/scientificamerican1191-104. [DOI] [PubMed] [Google Scholar]
  7. Corder E. H., Friedman G. D., Vogelman J. H., Orentreich N. Seasonal variation in vitamin D, vitamin D-binding protein, and dehydroepiandrosterone: risk of prostate cancer in black and white men. Cancer Epidemiol Biomarkers Prev. 1995 Sep;4(6):655–659. [PubMed] [Google Scholar]
  8. Corder E. H., Guess H. A., Hulka B. S., Friedman G. D., Sadler M., Vollmer R. T., Lobaugh B., Drezner M. K., Vogelman J. H., Orentreich N. Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol Biomarkers Prev. 1993 Sep-Oct;2(5):467–472. [PubMed] [Google Scholar]
  9. Coughlin S. S., Neaton J. D., Sengupta A. Cigarette smoking as a predictor of death from prostate cancer in 348,874 men screened for the Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1996 May 15;143(10):1002–1006. doi: 10.1093/oxfordjournals.aje.a008663. [DOI] [PubMed] [Google Scholar]
  10. Crawford E. D., Blumenstein B. A., Goodman P. J., Davis M. A., Eisenberger M. A., McLeod D. G., Spaulding J. T., Benson R., Dorr F. A. Leuprolide with and without flutamide in advanced prostate cancer. Cancer. 1990 Sep 1;66(5 Suppl):1039–1044. doi: 10.1002/cncr.1990.66.s5.1039. [DOI] [PubMed] [Google Scholar]
  11. Dale W., Vijayakumar S., Lawlor E. F., Merrell K. Prostate cancer, race, and socioeconomic status: inadequate adjustment for social factors in assessing racial differences. Prostate. 1996 Nov;29(5):271–281. doi: 10.1002/(SICI)1097-0045(199611)29:5<271::AID-PROS1>3.0.CO;2-D. [DOI] [PubMed] [Google Scholar]
  12. Dayal H. H., Chiu C. Factors associated with racial differences in survival for prostatic carcinoma. J Chronic Dis. 1982;35(7):553–560. doi: 10.1016/0021-9681(82)90074-1. [DOI] [PubMed] [Google Scholar]
  13. Demark-Wahnefried W., Strigo T., Catoe K., Conaway M., Brunetti M., Rimer B. K., Robertson C. N. Knowledge, beliefs, and prior screening behavior among blacks and whites reporting for prostate cancer screening. Urology. 1995 Sep;46(3):346–351. doi: 10.1016/S0090-4295(99)80218-0. [DOI] [PubMed] [Google Scholar]
  14. Doll J. A., Suarez B. K., Donis-Keller H. Association between prostate cancer in black Americans and an allele of the PADPRP pseudogene locus on chromosome 13. Am J Hum Genet. 1996 Feb;58(2):425–428. [PMC free article] [PubMed] [Google Scholar]
  15. Epstein J. I., Paull G., Eggleston J. C., Walsh P. C. Prognosis of untreated stage A1 prostatic carcinoma: a study of 94 cases with extended followup. J Urol. 1986 Oct;136(4):837–839. doi: 10.1016/s0022-5347(17)45097-x. [DOI] [PubMed] [Google Scholar]
  16. Fowler J. E., Jr, Terrell F. Survival in blacks and whites after treatment for localized prostate cancer. J Urol. 1996 Jul;156(1):133–136. [PubMed] [Google Scholar]
  17. Godley P. A., Campbell M. K., Miller C., Gallagher P., Martinson F. E., Mohler J. L., Sandler R. S. Correlation between biomarkers of omega-3 fatty acid consumption and questionnaire data in African American and Caucasian United States males with and without prostatic carcinoma. Cancer Epidemiol Biomarkers Prev. 1996 Feb;5(2):115–119. [PubMed] [Google Scholar]
  18. Hiatt R. A., Armstrong M. A., Klatsky A. L., Sidney S. Alcohol consumption, smoking, and other risk factors and prostate cancer in a large health plan cohort in California (United States). Cancer Causes Control. 1994 Jan;5(1):66–72. doi: 10.1007/BF01830728. [DOI] [PubMed] [Google Scholar]
  19. Hiatt R. A., Ordoñez J. D. Dipstick urinalysis screening, asymptomatic microhematuria, and subsequent urological cancers in a population-based sample. Cancer Epidemiol Biomarkers Prev. 1994 Jul-Aug;3(5):439–443. [PubMed] [Google Scholar]
  20. Hsing A. W., Comstock G. W. Serological precursors of cancer: serum hormones and risk of subsequent prostate cancer. Cancer Epidemiol Biomarkers Prev. 1993 Jan-Feb;2(1):27–32. [PubMed] [Google Scholar]
  21. Hsing A. W., McLaughlin J. K., Schuman L. M., Bjelke E., Gridley G., Wacholder S., Chien H. T., Blot W. J. Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study. Cancer Res. 1990 Nov 1;50(21):6836–6840. [PubMed] [Google Scholar]
  22. Hussain F., Aziz H., Macchia R., Avitable M., Rotman M. High grade adenocarcinoma of prostate in smokers of ethnic minority groups and Caribbean Island immigrants. Int J Radiat Oncol Biol Phys. 1992;24(3):451–461. doi: 10.1016/0360-3016(92)91059-v. [DOI] [PubMed] [Google Scholar]
  23. Ingles S. A., Haile R. W., Henderson B. E., Kolonel L. N., Nakaichi G., Shi C. Y., Yu M. C., Ross R. K., Coetzee G. A. Strength of linkage disequilibrium between two vitamin D receptor markers in five ethnic groups: implications for association studies. Cancer Epidemiol Biomarkers Prev. 1997 Feb;6(2):93–98. [PubMed] [Google Scholar]
  24. Kim J. A., Kuban D. A., el-Mahdi A. M., Schellhammer P. F. Carcinoma of the prostate: race as a prognostic indicator in definitive radiation therapy. Radiology. 1995 Feb;194(2):545–549. doi: 10.1148/radiology.194.2.7529936. [DOI] [PubMed] [Google Scholar]
  25. Lawton C. A., Cantrell J. E., Derus S. W., Murray K. J., Byhardt R. W., Wilson J. F. Prostate cancer: are racial differences in clinical stage and survival explained by differences in symptoms? Radiology. 1994 Jul;192(1):37–40. doi: 10.1148/radiology.192.1.8208961. [DOI] [PubMed] [Google Scholar]
  26. Levine R. L., Wilchinsky M. Adenocarcinoma of the prostate: a comparison of the disease in blacks versus whites. J Urol. 1979 Jun;121(6):761–762. doi: 10.1016/s0022-5347(17)56981-5. [DOI] [PubMed] [Google Scholar]
  27. Lyn D., Cherney B. W., Lalande M., Berenson J. R., Lichtenstein A., Lupold S., Bhatia K. G., Smulson M. A duplicated region is responsible for the poly(ADP-ribose) polymerase polymorphism, on chromosome 13, associated with a predisposition to cancer. Am J Hum Genet. 1993 Jan;52(1):124–134. [PMC free article] [PubMed] [Google Scholar]
  28. Matzkin H., Soloway M. S. Cigarette smoking: a review of possible associations with benign prostatic hyperplasia and prostate cancer. Prostate. 1993;22(4):277–290. doi: 10.1002/pros.2990220402. [DOI] [PubMed] [Google Scholar]
  29. Mettlin C., Murphy G. P., Menck H. Trends in treatment of localized prostate cancer by radical prostatectomy: observations from the Commission on Cancer National Cancer Database, 1985-1990. Urology. 1994 Apr;43(4):488–492. doi: 10.1016/0090-4295(94)90236-4. [DOI] [PubMed] [Google Scholar]
  30. Monroe K. R., Yu M. C., Kolonel L. N., Coetzee G. A., Wilkens L. R., Ross R. K., Henderson B. E. Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nat Med. 1995 Aug;1(8):827–829. doi: 10.1038/nm0895-827. [DOI] [PubMed] [Google Scholar]
  31. Moul J. W., Douglas T. H., McCarthy W. F., McLeod D. G. Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting. J Urol. 1996 May;155(5):1667–1673. [PubMed] [Google Scholar]
  32. Murphy G. P. Prostate cancer today. Urology. 1981 Mar;17(Suppl 3):1–3. [PubMed] [Google Scholar]
  33. Natarajan N., Murphy G. P., Mettlin C. Prostate cancer in blacks: an update from the American College of Surgeons' patterns of care studies. J Surg Oncol. 1989 Apr;40(4):232–236. doi: 10.1002/jso.2930400406. [DOI] [PubMed] [Google Scholar]
  34. Optenberg S. A., Thompson I. M., Friedrichs P., Wojcik B., Stein C. R., Kramer B. Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. JAMA. 1995 Nov 22;274(20):1599–1605. [PubMed] [Google Scholar]
  35. Page W. F., Kuntz A. J. Racial and socioeconomic factors in cancer survival. A comparison of Veterans Administration results with selected studies. Cancer. 1980 Mar 1;45(5):1029–1040. doi: 10.1002/1097-0142(19800301)45:5<1029::aid-cncr2820450533>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  36. Perez C. A., Garcia D., Simpson J. R., Zivnuska F., Lockett M. A. Factors influencing outcome of definitive radiotherapy for localized carcinoma of the prostate. Radiother Oncol. 1989 Sep;16(1):1–21. doi: 10.1016/0167-8140(89)90066-2. [DOI] [PubMed] [Google Scholar]
  37. Pienta K. J., Demers R., Hoff M., Kau T. Y., Montie J. E., Severson R. K. Effect of age and race on the survival of men with prostate cancer in the Metropolitan Detroit tricounty area, 1973 to 1987. Urology. 1995 Jan;45(1):93–102. doi: 10.1016/s0090-4295(95)96996-9. [DOI] [PubMed] [Google Scholar]
  38. Powell I. J., Schwartz K., Hussain M. Removal of the financial barrier to health care: does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system. Urology. 1995 Dec;46(6):825–830. doi: 10.1016/S0090-4295(99)80352-5. [DOI] [PubMed] [Google Scholar]
  39. Reichardt J. K., Makridakis N., Henderson B. E., Yu M. C., Pike M. C., Ross R. K. Genetic variability of the human SRD5A2 gene: implications for prostate cancer risk. Cancer Res. 1995 Sep 15;55(18):3973–3975. [PubMed] [Google Scholar]
  40. Reichman M. E., Hayes R. B., Ziegler R. G., Schatzkin A., Taylor P. R., Kahle L. L., Fraumeni J. F., Jr Serum vitamin A and subsequent development of prostate cancer in the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Cancer Res. 1990 Apr 15;50(8):2311–2315. [PubMed] [Google Scholar]
  41. Roach M., 3rd, Alexander M. The prognostic significance of race and survival from breast cancer: a model for assessing the reliability of reported survival differences. J Natl Med Assoc. 1995 Mar;87(3):214–219. [PMC free article] [PubMed] [Google Scholar]
  42. Roach M., 3rd, Krall J., Keller J. W., Perez C. A., Sause W. T., Doggett R. L., Rotman M., Russ H., Pilepich M. V., Asbell S. O. The prognostic significance of race and survival from prostate cancer based on patients irradiated on Radiation Therapy Oncology Group protocols (1976-1985). Int J Radiat Oncol Biol Phys. 1992;24(3):441–449. doi: 10.1016/0360-3016(92)91058-u. [DOI] [PubMed] [Google Scholar]
  43. Rodriguez C., Tatham L. M., Thun M. J., Calle E. E., Heath C. W., Jr Smoking and fatal prostate cancer in a large cohort of adult men. Am J Epidemiol. 1997 Mar 1;145(5):466–475. doi: 10.1093/oxfordjournals.aje.a009129. [DOI] [PubMed] [Google Scholar]
  44. Rotimi C., Austin H., Delzell E., Day C., Macaluso M., Honda Y. Retrospective follow-up study of foundry and engine plant workers. Am J Ind Med. 1993 Oct;24(4):485–498. doi: 10.1002/ajim.4700240412. [DOI] [PubMed] [Google Scholar]
  45. Silverberg E. Cancer statistics, 1980. CA Cancer J Clin. 1980 Jan-Feb;30(1):23–38. doi: 10.3322/canjclin.30.1.23. [DOI] [PubMed] [Google Scholar]
  46. Steele R., Lees R. E., Kraus A. S., Rao C. Sexual factors in the epidemiology of cancer of the prostate. J Chronic Dis. 1971 Jun;24(1):29–37. doi: 10.1016/0021-9681(71)90056-7. [DOI] [PubMed] [Google Scholar]
  47. Taylor J. A., Hirvonen A., Watson M., Pittman G., Mohler J. L., Bell D. A. Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res. 1996 Sep 15;56(18):4108–4110. [PubMed] [Google Scholar]
  48. Vogelzang N. J., Chodak G. W., Soloway M. S., Block N. L., Schellhammer P. F., Smith J. A., Jr, Caplan R. J., Kennealey G. T. Goserelin versus orchiectomy in the treatment of advanced prostate cancer: final results of a randomized trial. Zoladex Prostate Study Group. Urology. 1995 Aug;46(2):220–226. doi: 10.1016/s0090-4295(99)80197-6. [DOI] [PubMed] [Google Scholar]
  49. Walker A. R., Walker B. F., Segal I. Cancer patterns in three African populations compared with the United States black population. Eur J Cancer Prev. 1993 Jul;2(4):313–320. doi: 10.1097/00008469-199307000-00005. [DOI] [PubMed] [Google Scholar]
  50. Wu A. H., Whittemore A. S., Kolonel L. N., John E. M., Gallagher R. P., West D. W., Hankin J., Teh C. Z., Dreon D. M., Paffenbarger R. S., Jr Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada. Cancer Epidemiol Biomarkers Prev. 1995 Oct-Nov;4(7):735–741. [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES